Wyeth v. Levine and Its Implications

By Brian Wolfman, formerly of Public Citizen Litigation Group

Wyeth v. Levine and Its Implications

Brian Wolfman discusses the Supreme Court’s decision in Wyeth v. Levine, which held that FDA approval of a prescription drug and its labeling does not preempt a state-law suit seeking damages based on injuries caused by the failure of the drug’s manufacturer to warn about the drug’s dangers. This article appeared in The Bureau of National Affairs’s Product Safety & Liability Reporter.